Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer

Molecular Biology Reports

Volumn 41, Issue 5, 2014, Pages 3541-3547

  Akker, Mustafa ^a   Güldiken, Sibel ^a,b   Sipahi, Tammam ^a   Palabıyık, Orkide ^a   Tosunoğlu, Ayhan ^a   Çelik, Özlem ^c   Tunçbilek, Nermin ^a   Sezer, Atakan ^a   Süt, Necdet ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b School of Medicine   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ARGININE; CHOLESTEROL; CYTOSINE; GLUCOSE; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN BINDING PROTEIN 3; TRIACYLGLYCEROL; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN; IRS2 PROTEIN, HUMAN;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER PATIENT; CANCER STAGING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION TEST; TUMOR VOLUME; WAIST CIRCUMFERENCE; CANCER GRADING; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PATHOLOGY; THYROID TUMOR;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; NEOPLASM GRADING; POLYMORPHISM, GENETIC; RISK FACTORS; THYROID NEOPLASMS;

EID: 84905675898     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3218-2     Document Type: Article

References (50)

1. Enwold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 18:784
2. Tucker MA, Jones PH, Boice JD, Robison LL, Stone BJ, Stovall M et al (1991) Therapeutic radiation at a young age is linked to secondary thyroid cancer. The late effects study group. Cancer Res 51(11):2885-2888
3. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM et al (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141(3):259-277
4. Bosetti C, Kolonel L, Negri E, Ron E, Franceschi S, Maso LD et al (2001) A pooled analysis of case-control studies of thyroid cancer. VI. Fish and shellfish consumption. Cancer Causes Control 12(4):375-382 (Pubitemid 32564909)
5. Galanti MR, Ekbom A, Grimelius L, Yuen J (1997) Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 75(3):451-456 (Pubitemid 27051067)
6. Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS et al (2006) Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106(11):2376-2381 (Pubitemid 43787661)
7. Antoniadis AG, Petridou ET, Antonopoulos CN, Dessypris N, Panagopoulou P, Chamberland JP et al (2011) Insulin resistance in relation to melanoma risk. Melanoma Res 21(6):541-546
8. Siddique A, Kowdley KV (2011) Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis 15(2):281-296
9. Djiogue S, Nwabo Kamdje AH, Vecchio L, Kipanyula MJ, Farahna M, Aldebasi Y, Seke Etet PF (2013) Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer 20(1):R1-R17
10. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49(5):945-952
11. Fair AM, Dai Q, Shu XO, Matthews CE, Yu H, Jin F, Gao YT, Zheng W (2007) Energy balance, insulin resistance biomarkers, and breast cancer risk. Cancer Detect and Prev 31(3):214-219 (Pubitemid 47248150)
12. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16(4):1103-1123
13. Sara VR, Hall K (1990) Insulin-like growth factors and their binding proteins. Physiol Rev 70(3):591-614 (Pubitemid 20196044)
14. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A et al (1997) Acromegaly, colonic polyps and carcinoma. Clin Endocrinol 47(1):17-22 (Pubitemid 27313983)
15. Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB (2000) Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein - 3, and prostatespecific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 85(11):4258-4265 (Pubitemid 32055383)
16. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Nat Cancer Inst 91(2):151-156 (Pubitemid 29042692)
17. Malaguarnera R, Morcavallo A, Belfiore A (2012) The insulin and IGF-I pathway in endocrine glands carcinogenesis. J Oncol 2012:635614. doi:10.1155/2012/635614
18. Zhao ZG, Guo XG, Ba CX et al (2012) Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 40:2041-2050
19. Kitahara CM, Platz EA, Freeman LE et al (2011) Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 20:464-472
20. Rinaldi S, Lise M, Clavel-Chapelon F et al (2012) Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 131:E1004-E1014
21. Chan BT, Lee AV (2008) Insulin receptor substrates (IRSs) and breast tumorigenesis. J Mammary Gland Biol Neoplasia 13(4):415-422
22. Ouederni TB, Fadiel A, Stambouli N, Scalize TJ, Ben-Maiz H, Abid HK et al (2009) Influence of socioeconomic lifestyle factors and genetic polymorphism on type 2 diabetes occurrences among Tunisian Arab and Berber groups of Djerba Island. Pharmgenomics Pers Med 2:49-57
23. Ouederni TB, Sanches-Corona J, Flores-Martinez SE, Ben-Maiz H, Skhiri HA, Abid HK, Benammar-Elgaaied A (2009) The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population. Clin Biochem 42:1169-1173
24. Han SG, Park KH, Sung JS, Whang YM, Kim YJ, Shin ES et al (2008) Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population. Lung Cancer 62:152-161
25. Hursting SD (2012) Minireview: the year in obesity and cancer. Mol Endocrinol 26(12):1961-1966
26. Vucenik I, Stains JP (2012) Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci 1271:37-43
27. Pazaitou-Panayiotou K, Polyzos SA, Mantzoros CS (2013) Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms. Obes Rev. doi:10.1111/obr.12070
28. Kitahara CM, Platz EA, Park Y, Hollenbeck AR, Schatzkin A, Berrington de González A (2012) Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP diet and health study. Int J Cancer 130(6):1411-1419
29. Peterson E, De P, Nuttall R (2012) BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. Plasone 7(1):1-10
30. Leitzmann MF, Brenner A, Moore SC, Koebnick C, Park Y, Hollenbeck A et al (2010) Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer 126(12):2947-2956
31. Clero E, Leux C, Brindel P, Truong T, Anger A, Teinturier C et al (2010) Pooled analysis of two case - control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid 20(11):1285-1293
32. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB (2009) Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to moderate iodine-deficient area. Eur J Endocrinol 161:599-605
33. Rezzonico JN, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H (2009) Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 7(4):375-380
34. Sahin M, Uçan B, Giniş Z, Topaloǧlu O, Güngüneş A, Bozkurt NC et al (2013) Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol 30(2):589
35. Balkan F, Onal ED, Usluogullari A, Tuzun D, Ozdemir D, Inancli SS, Ersoy R, Cakir B (2013) Is there any association between insulin resistance and thyroid cancer? A case control study. 45(1):55-60
36. Hua SF, Xue FX, Zhang LZ, Wang YM, Zhao J (2008) Expression and activation of insulin receptor substrate-1 in endometrial carcinoma. Zhonghua Fu Chan Ke Za Zhi 43(6):437-441
37. Nowakowska-Zajdel E, Mazurek U, Ziolko E, Niedworok E, Fatyga E, Kokot T et al (2011) Analysis of expression profile of gene encoding proteins of signal cascades activated by insulin-like growth factors in colorectal cancer. Int J Immunopathol Pharmacol 24(3):781-787
38. Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT (2009) Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Res 11(5):1-12
39. Hoang CD, Zhang X, Scott PD, Guillaume TJ, Maddaus MA, Yee D et al (2004) Selective activation of insulin receptor substrate-1 and insulin receptor substrate-2 in pleural mesothelioma cells: association with distinct malignant phenotypes. Cancer Res 64(20):7479-7485 (Pubitemid 39372091)
40. Cayan F, Tok E, Aras-Ateş N, Ayaz L, Akbay E, Gen R et al (2010) Insulin receptor substrate-2 gene polymorphism: is it associatedwith endometrial cancer. Gynecol Endocrinol 26(5):378-382
41. Neuhausen SL, Slattery ML, Garner CP, Ding YC, Hoffman M, Brothman AR (2005) Prostate cancer risk and IRS-1, IRS-2, IGF-1, and INS polymorphisms: strong association of IRS-1 G972R variant and cancer risk. Prostate 64(2):168-174 (Pubitemid 40791766)
42. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363(9418):1346-1353 (Pubitemid 38529873)
43. Chen W, Wang S, Tian T et al (2009) Phenotypes and genotypes of insulin-like growth factor 1, IGF binding protein-3 and cancer risk: evidence from 96 studies. Eur J Hum Genet 17(12):1668-1675
44. McGrath M, Lee IM, Buring J, De Vivo I (2011) Common genetic variation within IGF-1, IGFI-2, IGFBP-1, and IGFBP-3 and endometrial cancer risk. Gynecol Oncol 120(2):174-178
45. Santosh V, Arivazhagan A, Sreekanthreddy P, Srinivasan H, Thota B, Srividya MR et al (2010) Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. Cancer Epidemiol Biomarkers Prev 19(6):1399-1408
46. Gigek CO, Leal MF, Lisboa LC, Silva PN, Chen ES, Lima EM et al (2010) Insulin-like growth factor binding protein-3 gene methylation and protein expression in gastric adenocarcinoma. Growth Horm IGF Res 20(3):234-238
47. Ressler S, Radhi J, Aigner T, Loo C, Zwerschke W, Sergi C (2009) Insulin-like growth factor-binding protein-3 in osteosarcomas and normal bone tissues. Anticancer Res 29(7):2579-2587
48. Zhao L, He LR, Zhang R, Cai MY, Liao YJ, Qian D et al (2012) Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Med Oncol 29:2669-2676
49. Safarinejad MR, Shafiei N, Safarinejad S (2011) Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I and IGFBP-3. Growth Horm IGF Res 21(3):146-154
50. Xu L, Mugartegui L, Li G, Sarlis NJ, Wei Q, Zafereo ME, Sturgis EM (2012) Functional polymorphisms in the insulin-like binding protein-3gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans. Mol Carcinog 51(Suppl 1):E158-E167